top of page
IRESSA (Gefitinib) is a chemotherapy medication that can be prescribed to treat a certain type of lung cancer. IRESSA is approved to treat metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations.

Iressa (Gefitinib)

  • The normal IRESSA dosage is 250 mg once daily until the disease becomes worse or the side effects of the drug are not tolerable. Take IRESSA exactly as prescribed by the oncologist. Do not take a missed dose if the next scheduled dose is 12 hours or less away.
bottom of page